Tech Company Financing Transactions
Roka Bioscience Funding Round
Aisling Capital, New Enterprise Associates and OrbiMed participated in a $47.5 million Series D capital raise for Roka Bioscience. The round was announced on 1/9/2012.
Transaction Overview
Aisling Capital (Lead Investor) (Joshua Bilenker)
New Enterprise Associates (James Barrett)
OrbiMed (Jonathan Silverstein)
TPG Biotech (Fred Cohen)
Company Information
Warren, NJ 07059
USA
Management Team
Browse more venture capital transactions:
Prev: 1/9/2012: Practice Fusion venture capital transaction
Next: 1/9/2012: BuzzFeed venture capital transaction
Share this article
Where The Data Comes From
We report on every notable VC transaction. VC investment data records on this site come from a variety of public sources. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs